Bank Julius Baer & Co. Ltd, Zurich Teva Pharmaceutical Industries LTD Transaction History

Bank Julius Baer & Co. Ltd, Zurich

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 09, 2022	SELL	$7.33 - $9.39 $113,615 - $145,545	-15,500 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$8.38 - $10.18 $377 - $458	45 Added 0.29%	15,500 $151,000
Q2 2021 Jul 23, 2021	SELL	$9.9 - $11.56 $445 - $520	-45 Reduced 0.29%	15,455 $153,000
Q1 2021 May 10, 2021	SELL	$10.34 - $12.81 $35,817 - $44,373	-3,464 Reduced 18.27%	15,500 $179,000
Q4 2020 Feb 24, 2021	SELL	$8.61 - $11.04 $309 - $397	-36 Reduced 0.19%	18,964 $183,000
Q4 2020 Feb 12, 2021	BUY	$8.61 - $11.04 $25,830 - $33,120	3,000 Added 18.75%	19,000 $183,000
Q3 2020 Nov 10, 2020	BUY	$8.57 - $12.69 $34,280 - $50,760	4,000 Added 33.33%	16,000 $144,000
Q2 2020 Aug 12, 2020	BUY	$8.12 - $13.12 $97,439 - $157,440	12,000 New	12,000 $148,000

626

573M

19.6M

6.77M

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $23.2B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

Get notified when there are updates to the investment portfolio of Bank Julius Baer & Co. Ltd, Zurich, based on Form 13F filings with the SEC.

Stay updated on Bank Julius Baer & Co. Ltd, Zurich with notifications on news.